TCGA Team Detects Signaling Pathway Alterations in Most Lung Adenocarcinoma Tumors | GenomeWeb

NEW YORK (GenomeWeb) – Members of the Cancer Genome Atlas today described driver mutations and potential drug targets detected in a common form of lung cancer called lung adenocarcinoma.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.